Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

Last updated: October 24, 2026 6:30 pm

A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.

Source: CNBC

Share This Article

ByThe True Post

The newsroom of The True Post.

Top Stories

NFL roundup: Falcons spoil Niners’ undefeated start; Steelers win in Paris

Ohio State replaces BYU at No. 2 as Top 25 jumbled again by top-10 losses

Sixers overrule Embiid, sit center with plantar fasciitis management

Stay Connected

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

Leave a Reply Cancel reply

Related Stories

Archdiocese sues US government over denied Catholic sacraments for ICE detainees

4 Dead in ‘Violent’ Fire at a Canadian Military Base

Wall Street rewards Microsoft's AI pivot. A longtime skeptic says it's just the beginning

Why visitors are flocking to Philadelphia's popular pigeon tour

Judge indefinitely blocks Trump from banning 3 media outlets from White House

FTC is investigating OpenAI, Anthropic and other AI companies over product risks

2 American tourists dead after building explosion in Greece

27-year-old started a run club to meet new people—now his NYC side hustle brings in $640K a year

Sections

The Newsroom